BACKGROUND: Schizophrenia is associated with lower pre-morbid intelligence (IQ) in addition to (pre-morbid) cognitive decline. Both schizophrenia and IQ are highly heritable traits. Therefore, we hypothesized that genetic variants associated with schizophrenia, including copy number variants (CNVs) and a polygenic schizophrenia (risk) score (PSS), may influence intelligence. METHOD: IQ was estimated with the Wechsler Adult Intelligence Scale (WAIS). CNVs were determined from single nucleotide polymorphism (SNP) data using the QuantiSNP and PennCNV algorithms. For the PSS, odds ratios for genome-wide SNP data were calculated in a sample collected by the Psychiatric Genome-Wide Association Study (GWAS) Consortium (8690 schizophrenia patients and 11 831 controls). These were used to calculate individual PSSs in our independent sample of 350 schizophrenia patients and 322 healthy controls. RESULTS: Although significantly more genes were disrupted by deletions in schizophrenia patients compared to controls (p = 0.009), there was no effect of CNV measures on IQ. The PSS was associated with disease status (R 2 = 0.055, p = 2.1 × 10-7) and with IQ in the entire sample (R 2 = 0.018, p = 0.0008) but the effect on IQ disappeared after correction for disease status. CONCLUSIONS: Our data suggest that rare and common schizophrenia-associated variants do not explain the variation in IQ in healthy subjects or in schizophrenia patients. Thus, reductions in IQ in schizophrenia patients may be secondary to other processes related to schizophrenia risk.
BACKGROUND: Schizophrenia is associated with lower pre-morbid intelligence (IQ) in addition to (pre-morbid) cognitive decline. Both schizophrenia and IQ are highly heritable traits. Therefore, we hypothesized that genetic variants associated with schizophrenia, including copy number variants (CNVs) and a polygenic schizophrenia (risk) score (PSS), may influence intelligence. METHOD: IQ was estimated with the Wechsler Adult Intelligence Scale (WAIS). CNVs were determined from single nucleotide polymorphism (SNP) data using the QuantiSNP and PennCNV algorithms. For the PSS, odds ratios for genome-wide SNP data were calculated in a sample collected by the Psychiatric Genome-Wide Association Study (GWAS) Consortium (8690 schizophrenia patients and 11 831 controls). These were used to calculate individual PSSs in our independent sample of 350 schizophrenia patients and 322 healthy controls. RESULTS: Although significantly more genes were disrupted by deletions in schizophrenia patients compared to controls (p = 0.009), there was no effect of CNV measures on IQ. The PSS was associated with disease status (R 2 = 0.055, p = 2.1 × 10-7) and with IQ in the entire sample (R 2 = 0.018, p = 0.0008) but the effect on IQ disappeared after correction for disease status. CONCLUSIONS: Our data suggest that rare and common schizophrenia-associated variants do not explain the variation in IQ in healthy subjects or in schizophrenia patients. Thus, reductions in IQ in schizophrenia patients may be secondary to other processes related to schizophrenia risk.
Authors: Timothea Toulopoulou; Marco Picchioni; Fruhling Rijsdijk; Mei Hua-Hall; Ulrich Ettinger; Pak Sham; Robin Murray Journal: Arch Gen Psychiatry Date: 2007-12
Authors: Jacobine E Buizer-Voskamp; Jan-Willem Muntjewerff; Eric Strengman; Chiara Sabatti; Hreinn Stefansson; Jacob A S Vorstman; Roel A Ophoff Journal: Biol Psychiatry Date: 2011-04-13 Impact factor: 13.382
Authors: Abraham Reichenberg; Avshalom Caspi; Honalee Harrington; Renate Houts; Richard S E Keefe; Robin M Murray; Richie Poulton; Terrie E Moffitt Journal: Am J Psychiatry Date: 2010-01-04 Impact factor: 18.112
Authors: Ian J Deary; Jian Yang; Gail Davies; Sarah E Harris; Albert Tenesa; David Liewald; Michelle Luciano; Lorna M Lopez; Alan J Gow; Janie Corley; Paul Redmond; Helen C Fox; Suzanne J Rowe; Paul Haggarty; Geraldine McNeill; Michael E Goddard; David J Porteous; Lawrence J Whalley; John M Starr; Peter M Visscher Journal: Nature Date: 2012-01-18 Impact factor: 49.962
Authors: Afke F Terwisscha van Scheltinga; Steven C Bakker; Neeltje E M van Haren; Eske M Derks; Jacobine E Buizer-Voskamp; Heleen B M Boos; Wiepke Cahn; Hilleke E Hulshoff Pol; Stephan Ripke; Roel A Ophoff; René S Kahn Journal: Biol Psychiatry Date: 2012-10-03 Impact factor: 13.382
Authors: Gabriëlla A M Blokland; Raquelle I Mesholam-Gately; Timothea Toulopoulou; Elisabetta C Del Re; Max Lam; Lynn E DeLisi; Gary Donohoe; James T R Walters; Larry J Seidman; Tracey L Petryshen Journal: Schizophr Bull Date: 2017-07-01 Impact factor: 9.306
Authors: W D Hill; G Davies; L N van de Lagemaat; A Christoforou; R E Marioni; C P D Fernandes; D C Liewald; M D R Croning; A Payton; L C A Craig; L J Whalley; M Horan; W Ollier; N K Hansell; M J Wright; N G Martin; G W Montgomery; V M Steen; S Le Hellard; T Espeseth; A J Lundervold; I Reinvang; J M Starr; N Pendleton; S G N Grant; T C Bates; I J Deary Journal: Transl Psychiatry Date: 2014-01-07 Impact factor: 6.222
Authors: Gabriëlla A M Blokland; Elisabetta C Del Re; Raquelle I Mesholam-Gately; Jorge Jovicich; Joey W Trampush; Matcheri S Keshavan; Lynn E DeLisi; James T R Walters; Jessica A Turner; Anil K Malhotra; Todd Lencz; Martha E Shenton; Aristotle N Voineskos; Dan Rujescu; Ina Giegling; René S Kahn; Joshua L Roffman; Daphne J Holt; Stefan Ehrlich; Zora Kikinis; Paola Dazzan; Robin M Murray; Marta Di Forti; Jimmy Lee; Kang Sim; Max Lam; Rick P F Wolthusen; Sonja M C de Zwarte; Esther Walton; Donna Cosgrove; Sinead Kelly; Nasim Maleki; Lisa Osiecki; Marco M Picchioni; Elvira Bramon; Manuela Russo; Anthony S David; Valeria Mondelli; Antje A T S Reinders; M Aurora Falcone; Annette M Hartmann; Bettina Konte; Derek W Morris; Michael Gill; Aiden P Corvin; Wiepke Cahn; New Fei Ho; Jian Jun Liu; Richard S E Keefe; Randy L Gollub; Dara S Manoach; Vince D Calhoun; S Charles Schulz; Scott R Sponheim; Donald C Goff; Stephen L Buka; Sara Cherkerzian; Heidi W Thermenos; Marek Kubicki; Paul G Nestor; Erin W Dickie; Evangelos Vassos; Simone Ciufolini; Tiago Reis Marques; Nicolas A Crossley; Shaun M Purcell; Jordan W Smoller; Neeltje E M van Haren; Timothea Toulopoulou; Gary Donohoe; Jill M Goldstein; Larry J Seidman; Robert W McCarley; Tracey L Petryshen Journal: Schizophr Res Date: 2017-10-03 Impact factor: 4.939
Authors: T Lencz; E Knowles; G Davies; S Guha; D C Liewald; J M Starr; S Djurovic; I Melle; K Sundet; A Christoforou; I Reinvang; S Mukherjee; Pamela DeRosse; A Lundervold; V M Steen; M John; T Espeseth; K Räikkönen; E Widen; A Palotie; J G Eriksson; I Giegling; B Konte; M Ikeda; P Roussos; S Giakoumaki; K E Burdick; A Payton; W Ollier; M Horan; G Donohoe; D Morris; A Corvin; M Gill; N Pendleton; N Iwata; A Darvasi; P Bitsios; D Rujescu; J Lahti; S L Hellard; M C Keller; O A Andreassen; I J Deary; D C Glahn; A K Malhotra Journal: Mol Psychiatry Date: 2013-12-17 Impact factor: 15.992
Authors: S Papiol; M Mitjans; F Assogna; F Piras; C Hammer; C Caltagirone; B Arias; H Ehrenreich; G Spalletta Journal: Transl Psychiatry Date: 2014-02-18 Impact factor: 6.222
Authors: Leon Hubbard; Katherine E Tansey; Dheeraj Rai; Peter Jones; Stephan Ripke; Kimberly D Chambert; Jennifer L Moran; Steven A McCarroll; David E J Linden; Michael J Owen; Michael C O'Donovan; James T R Walters; Stanley Zammit Journal: Schizophr Bull Date: 2015-12-16 Impact factor: 9.306